Table 1.
Variables | 28-days neonatal status |
||||
---|---|---|---|---|---|
Died (%) | Survived (%) | ||||
Maternal residence | |||||
Rural | 23 (21.3) | 85 (78.7) | |||
Urban | 40 (15.6) | 217 (84.4) | |||
Maternal age | |||||
<20 | 5 (19.2) | 21 (80.8) | |||
21–35 | 50 (16.8) | 247 (83.2) | |||
>35 | 8 (25.0) | 24 (75.0) | |||
Maternal HIV status | |||||
Positive | 8 (19.5) | 33 (80.5) | |||
Negative | 55 (17.3) | 263 (82.7) | |||
Iron-foliate supplementation | |||||
No | 47 (14.9) | 268 (85.1) | |||
Yes | 16 (32.0) | 34 (68.0) | |||
Planned pregnancy | |||||
No | 6 (13.0) | 40 (87.0) | |||
Yes | 75 (22.3) | 262 (77.7) | |||
Pregnancy-induced hypertension | |||||
No | 38 (13.3) | 247 (86.7) | |||
Yes | 25 (31.2) | 55 (68.8) | |||
Anemia during pregnancy | |||||
No | 51 (15.4) | 280 (84.6) | |||
Yes | 10 (31.2) | 22 (68.8) | |||
Inter-birth interval | |||||
≥24 months | 20 (16.7) | 100 (83.3) | |||
<24 months | 43 (15.6) | 202 (84.4) | |||
Malaria prevention counseling during pregnancy | |||||
No | 34 (23.4) | 111 (76.6) | |||
Yes | 29 (13.2) | 191 (86.8) | |||
Fetal movement reduction | |||||
No | 55 (16.1) | 286 (83.9) | |||
Yes | 8 (33.3) | 16 (66.7) | |||
5 minutes Apgar score | |||||
≥7 | 32 (12.9) | 217 (87.1) | |||
<7 | 31 (26.7) | 85 (73.3) | |||
Sex of the newborn | |||||
Male | 37 (16.6) | 186 (83.4) | |||
Female | 26 (18.3) | 116 (81.7) | |||
Birth asphyxia | |||||
No | 42 (13.5) | 269 (86.5) | |||
Yes | 21 (25.0) | 33 (75.0) | |||
Birth weight | |||||
≥2500 | 17 (8.3) | 188 (91.7) | |||
<2500 | 46 (28.8) | 114 (71.2) | |||
Gestational age | |||||
≥37 weeks | 20 (7.8) | 238 (92.2) | |||
<37 weeks | 43 (40.2) | 64 (59.8) | |||
NICU admission | |||||
No | 6 (9.8) | 55 (90.2) | |||
Yes | 57 (18.7) | 247 (81.3) |